Profacgen Launches Single Molecule Array Testing Service for Protein Analysis Research

Profacgen, a leading provider of protein research services, today announced the launch of its Single Molecule Array (SiMoA) testing service. This highly sensitive technology enables researchers to detect ultra-low abundance proteins with unparalleled accuracy, opening up new possibilities for biomarker discovery and disease research.

SiMoA is a revolutionary technology that brings protein detection into the era of single-molecule analysis. By coating tiny magnetic beads with hundreds of thousands of capture antibodies, SiMoA achieves a sensitivity that is thousands of times greater than traditional ELISA methods. This allows researchers to detect proteins at femtogram concentrations, making it an invaluable tool for the discovery of novel biomarkers and the early detection of diseases.

"We are thrilled to offer SiMoA testing as part of our suite of protein analysis services," said Ellen, Chief Marketing Officer at Profacgen. "Our team of experienced scientists, combined with our state-of-the-art equipment, enables us to provide researchers with the most accurate and sensitive protein detection available. We are confident that SiMoA will be a game-changer for protein research and biomarker discovery."

Profacgen's SiMoA service offers several key advantages over traditional protein detection methods. In addition to its unparalleled sensitivity, SiMoA is fully automated, reducing manual errors and increasing efficiency. It also enables high-throughput detection, with the ability to analyze 288 samples simultaneously and up to 500 samples in a single day. Furthermore, SiMoA can accommodate a variety of sample types, including serum, plasma, urine, saliva, and cell lysates.

"By providing access to single molecule array technology, we aim to empower researchers to push the boundaries of protein research and biomarker discovery," continued Ellen. "Our goal is to support the scientific community in their quest for new insights into disease mechanisms and the development of novel therapeutic strategies."

Researchers interested in leveraging the power of SiMoA for their protein analysis needs can contact Profacgen to discuss their project requirements or visit https://www.profacgen.com/single-molecular-array-testing.htm directly. With its expertise in protein research and commitment to delivering the most accurate and sensitive results, Profacgen is the ideal partner for researchers seeking to advance their understanding of the proteome.